IBDEI0PK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12535,1,8,0)
 ;;=8^Enterostomy Status Nec
 ;;^UTILITY(U,$J,358.3,12535,2)
 ;;=^295450
 ;;^UTILITY(U,$J,358.3,12536,0)
 ;;=V44.50^^70^768^9
 ;;^UTILITY(U,$J,358.3,12536,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12536,1,1,0)
 ;;=1^V44.50
 ;;^UTILITY(U,$J,358.3,12536,1,8,0)
 ;;=8^Unsp Cystostomy Status
 ;;^UTILITY(U,$J,358.3,12536,2)
 ;;=^321540
 ;;^UTILITY(U,$J,358.3,12537,0)
 ;;=V44.6^^70^768^10
 ;;^UTILITY(U,$J,358.3,12537,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12537,1,1,0)
 ;;=1^V44.6
 ;;^UTILITY(U,$J,358.3,12537,1,8,0)
 ;;=8^Urostomy Status NEC
 ;;^UTILITY(U,$J,358.3,12537,2)
 ;;=^295453
 ;;^UTILITY(U,$J,358.3,12538,0)
 ;;=V44.7^^70^768^3
 ;;^UTILITY(U,$J,358.3,12538,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12538,1,1,0)
 ;;=1^V44.7
 ;;^UTILITY(U,$J,358.3,12538,1,8,0)
 ;;=8^Artificial Vagina Status
 ;;^UTILITY(U,$J,358.3,12538,2)
 ;;=^295455
 ;;^UTILITY(U,$J,358.3,12539,0)
 ;;=V44.8^^70^768^1
 ;;^UTILITY(U,$J,358.3,12539,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12539,1,1,0)
 ;;=1^V44.8
 ;;^UTILITY(U,$J,358.3,12539,1,8,0)
 ;;=8^Artif Open Status Nec
 ;;^UTILITY(U,$J,358.3,12539,2)
 ;;=^295456
 ;;^UTILITY(U,$J,358.3,12540,0)
 ;;=V44.9^^70^768^2
 ;;^UTILITY(U,$J,358.3,12540,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12540,1,1,0)
 ;;=1^V44.9
 ;;^UTILITY(U,$J,358.3,12540,1,8,0)
 ;;=8^Artif Open Status Nos
 ;;^UTILITY(U,$J,358.3,12540,2)
 ;;=^295457
 ;;^UTILITY(U,$J,358.3,12541,0)
 ;;=V10.72^^70^769^19
 ;;^UTILITY(U,$J,358.3,12541,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12541,1,1,0)
 ;;=1^V10.72
 ;;^UTILITY(U,$J,358.3,12541,1,8,0)
 ;;=8^Hx-Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,12541,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,12542,0)
 ;;=V10.71^^70^769^22
 ;;^UTILITY(U,$J,358.3,12542,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12542,1,1,0)
 ;;=1^V10.71
 ;;^UTILITY(U,$J,358.3,12542,1,8,0)
 ;;=8^Hx-Lymphosarcoma
 ;;^UTILITY(U,$J,358.3,12542,2)
 ;;=^295236
 ;;^UTILITY(U,$J,358.3,12543,0)
 ;;=V10.05^^70^769^5
 ;;^UTILITY(U,$J,358.3,12543,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12543,1,1,0)
 ;;=1^V10.05
 ;;^UTILITY(U,$J,358.3,12543,1,8,0)
 ;;=8^Hx Of Colonic Malignancy
 ;;^UTILITY(U,$J,358.3,12543,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,12544,0)
 ;;=V10.03^^70^769^17
 ;;^UTILITY(U,$J,358.3,12544,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12544,1,1,0)
 ;;=1^V10.03
 ;;^UTILITY(U,$J,358.3,12544,1,8,0)
 ;;=8^Hx-Esophageal Malignancy
 ;;^UTILITY(U,$J,358.3,12544,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,12545,0)
 ;;=V10.07^^70^769^10
 ;;^UTILITY(U,$J,358.3,12545,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12545,1,1,0)
 ;;=1^V10.07
 ;;^UTILITY(U,$J,358.3,12545,1,8,0)
 ;;=8^Hx Of Liver Malignancy
 ;;^UTILITY(U,$J,358.3,12545,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,12546,0)
 ;;=V10.06^^70^769^30
 ;;^UTILITY(U,$J,358.3,12546,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12546,1,1,0)
 ;;=1^V10.06
 ;;^UTILITY(U,$J,358.3,12546,1,8,0)
 ;;=8^Hx-Rectal   Anal Malign
 ;;^UTILITY(U,$J,358.3,12546,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,12547,0)
 ;;=V10.04^^70^769^7
 ;;^UTILITY(U,$J,358.3,12547,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12547,1,1,0)
 ;;=1^V10.04
 ;;^UTILITY(U,$J,358.3,12547,1,8,0)
 ;;=8^Hx Of Gastric Malignancy
 ;;^UTILITY(U,$J,358.3,12547,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,12548,0)
 ;;=V10.09^^70^769^8
 ;;^UTILITY(U,$J,358.3,12548,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12548,1,1,0)
 ;;=1^V10.09
 ;;^UTILITY(U,$J,358.3,12548,1,8,0)
 ;;=8^Hx Of Gi Malignancy Nec
 ;;^UTILITY(U,$J,358.3,12548,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,12549,0)
 ;;=V10.01^^70^769^13
